Article info

other Versions

PDF

Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?

Authors

  • David Charles Hutchings Unit of Cardiac Physiology, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK PubMed articlesGoogle scholar articles
  • Simon George Anderson Unit of Cardiac Physiology, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK PubMed articlesGoogle scholar articles
  • Jessica L Caldwell Unit of Cardiac Physiology, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK PubMed articlesGoogle scholar articles
  • Andrew W Trafford Unit of Cardiac Physiology, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr David Charles Hutchings, Institute of Cardiovascular Sciences, The University of Manchester, Manchester, M13 9NT, UK; david.hutchings-2{at}manchester.ac.uk
View Full Text

Citation

Hutchings DC, Anderson SG, Caldwell JL, et al
Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?

Publication history

  • Received December 14, 2017
  • Revised February 8, 2018
  • Accepted February 12, 2018
  • First published March 8, 2018.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.